2025-02-12 – Press Releases – www.prnewswire.com
SINGAPORE, Feb. 12, 2025 /PRNewswire/ — On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an international multicenter Phase 2 clinical…